Seres Therapeutics (MCRB)

8.88 +0.14 (1.60%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/2/18 *Est.)

Latest Headlines

Form 4 Seres Therapeutics, Inc. For: Jun 15 Filed by: Aunins John G. June 18, 2018 4:44 PM - SEC Filing Seres Therapeutics to Present at Two Upcoming June Conferences June 1, 2018 7:00 AM - BizWire Seres Therapeutics to Host Microbiome R&D Event and Webcast on May 24, 2018 May 17, 2018 7:00 AM - BizWire Form 4 Seres Therapeutics, Inc. For: May 09 Filed by: Pomerantz Roger May 10, 2018 4:55 PM - SEC Filing Form 10-Q Seres Therapeutics, Inc. For: Mar 31 May 9, 2018 9:44 AM - SEC Filing Seres Therapeutics (MCRB) Reports Q1 Revenues Above Consensus May 9, 2018 7:15 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: May 09 May 9, 2018 7:13 AM - SEC Filing Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Updates May 9, 2018 7:00 AM - BizWire Seres Therapeutics to Host First Quarter 2018 Financial Results and Operational Progress Conference Call and Webcast on May 9, 2018 May 7, 2018 7:00 AM - BizWire Seres Therapeutics to Present at Two Upcoming May Conferences May 4, 2018 7:00 AM - BizWire Form DEFA14A Seres Therapeutics, Inc. April 30, 2018 5:09 PM - SEC Filing Form DEF 14A Seres Therapeutics, Inc. For: Jun 26 April 30, 2018 5:08 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Apr 25 Filed by: Aunins John G. April 26, 2018 5:09 PM - SEC Filing Seres Therapeutics (MCRB) Presents New Preclinical Data Supporting the Development of Microbiome Therapeutics for Immuno-Oncology at AACR April 17, 2018 12:00 PM - StreetInsider Seres Therapeutics Presents New Preclinical Data Supporting the Development of Microbiome Therapeutics for Immuno-Oncology at the 2018 American Association for Cancer Research Annual Meeting April 17, 2018 12:00 PM - BizWire Form SC 13D Seres Therapeutics, Inc. Filed by: Nestle Health Science US Holdings, Inc. April 11, 2018 6:04 AM - SEC Filing Full Article List